logo
Explore dividend stocks

Laboratorios Farmaceuticos Rovi, S.A

Add to watchlist
€46.7
Last updated:04/20/2021
41L: F
Laboratorios Farmaceuticos Rovi, S.A

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal p… Show more

Dividend yield
0.37%
€0.175 anually

3y growth is 20.45%

P/E ratio
42.38x
vs. 30.67x forward

Price is 42.38x times more than EPS €1.1 which eaquals €46.7

Payout ratio
15.89%
Yearly

15.89% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company debt level

Become our supporter to unlock all data!
41L dividends
Payout frequency
year
Latest ex-date
11/17/2020
3y growth
20.45%
5y growth
-3.62%
2020
Increase
€0.175
11/17/2020
€0.175
2019
€0.08
07/02/2019
€0.08
2018
€0.121
07/03/2018
€0.121
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
17.241M
17.895M
+3.79%
39.273M
+119.46%
61.057M
+55.47%
Cashflow
Sum up money going in and out company
18.039M
8.531M
-52.71%
-9.044M
-206.01%
46.876M
+618.31%
Total liabilities
All combined debts and obligations
106.695M
115.228M
+8.00%
188.825M
+63.87%
200.739M
+6.31%
Company profile
CEO
Mr. Juan Lopez-Belmonte Encina
Market capitalization
Mid (2.57B)